Glecirasib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Glecirasib, covering 2025-09-10 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC [Phase 1, Phase 2]